期刊文献+

2型猪链球菌细胞壁蛋白SSU1664的表达、纯化及活性分析

Expression,purification and activity assay of Streptococcus suis serotype 2 cell wall protein SSU1664
下载PDF
导出
摘要 目的:从猪链球菌05ZY中扩增SSU1664基因,在大肠杆菌中表达并评价其重组蛋白的活性。方法:根据05ZY基因组序列设计引物,PCR扩增SSU1664基因,构建表达载体,利用亲和层析对目的蛋白进行纯化,Western blot和ELISA法鉴定其免疫原性。结果:SSU1664基因能够在大肠杆菌中可溶性表达,Western blot显示其能与猪链球菌菌体免疫后的大鼠血清反应,ELISA检测显示在人感染猪链球菌患者血清中针对SSU1664蛋白的IgM含量显著性升高。结论:SSU1664蛋白具有较高的免疫原性,可作为潜在的猪链球菌疫苗候选分子和猪链球菌早期感染诊断的标志物。 AIM:To amplify the SSU1664 gene from Streptococcus suis serotype 2 strain 05ZY,to express the gene in E.coli,and to evaluate the activities of the recombinant protein.METHODS:SSU1664 gene was amplified by PCR using primers according to 05ZY genome sequences and cloned into the expression vector.The recombinant protein was purified by affinity chromatography and its immunogen activities were tested by Western blot and ELISA.RESULTS:SSU1664 gene could solublely express in E.coli BL21(DE3).Western blot analysis showed that the recombinant protein could react with rat serum immunized with Streptococcus suis,but not with non-immunized rat serum.ELISA assay showed that anti-SSU1664 IgM content in Streptococcus suis-infected patient was significantly higher than that in healthy donors.CONCLUSION:The recombinant SSU1664 protein has immunogen activity and might be one promising Streptococcus suis vaccine candidate and diagnosis marker of Streptococcus suis early infection.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2011年第7期757-759,共3页 Chinese Journal of Cellular and Molecular Immunology
基金 国家自然科学基金资助项目(30870091)
关键词 猪链球菌 细胞壁蛋白 疫苗 Streptococcus suis cell wall protein vaccine
  • 相关文献

参考文献11

  • 1Feng Y, Zhang H, Ma Y, et al. Uncovering newly emerging variants of Streptococcus suis, an important zoonotic agent [J]. Trends Micro- biol, 2010, 18(3): 124-131.
  • 2Segura M. Streptococcus suis: an emerging human threat [ J ]. Infect Dis, 2009, 199(1) : 4-6.
  • 3Gottschalk M, Segura M, Xu J. Streptococcus suis infections in hu- mans : the Chinese experience and the situation in North America [ J ]. Anim Health Res Rev, 2007, 8 ( 1 ) : 29 - 45.
  • 4Gottschalk M, Xu J, Calzas C, et al. Streptococcus suis : a new emer- ging or an old neglected zoonotic pathogen? [J]. Future Microbiol, 2010, 5(3) : 371 -391.
  • 5Gottschalk M, Segura M. The pathogenesis of the meningitis caused by Streptococcus suis: the unresolved questions [ J ]. Vet Microbiol, 2000, 76 (3) : 259 - 272.
  • 6Ye C, Bai X, Zhang J, et al. Spread of Streptococcus suis sequence type 7, China[J]. Emerg Infect Dis, 2008 , 14(5) : 787 -791.
  • 7Baums CG, Valentin-Weigand P. Surface-associated and secreted fac- tom of Streptococcus suis in epidemiology, pathogenesis and vaccine development [ J]. Anita Health Res Rev, 2009, 10 ( 1 ) : 65 - 83.
  • 8Geng H, Zhu L, Yuan Y, et al. Identification and characterization of novel immunogenic proteins of Streptococcus suis serotype 2 [J]. Pro- teome Res, 2008, 7(9) : 4132 -4142.
  • 9Fenno JC, Tamura M, Hannam PM, et al. Identification of a Trepone- ma denticola OppA homologue that binds host proteins present in the subgingival environment [ J ]. Infect Immun, 2000, 68 (4) : 1884 - 1892.
  • 10Henrich B, Hopfe M, Kitzerow A, et al. The adherence-associated lipoprotein P100, encoded by an opp operon structure, functions as the oligopeptide-binding domain OppA of a putative oligopeptide transport system in Mycoplasma hominis [ J ]. Bacteriol, 1999, 181 (16) : 4873 -4878.

二级参考文献9

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部